Global Sciatica Treatment Market

Sciatica Treatment Market Size, Share, Growth Analysis, By Drug class(Non-steroidal anti-inflammatory drugs, Steroids), By Type(Acute sciatica, Chronic sciatica), By Distribution channel(Hospital pharmacies, Retail & specialty pharmacies) - Industry Forecast 2024-2031


Report ID: SQMIG35A2822 | Region: Global | Published Date: April, 2024
Pages: 219 | Tables: 90 | Figures: 72

Sciatica Treatment Market Insights

Global Sciatica Treatment Market size was valued at USD 705.80 billion in 2022 and is poised to grow from USD 734.74 billion in 2023 to USD 1013.30 billion by 2031, growing at a CAGR of 4.1% in the forecast period (2024-2031).

Sciatica is radiating pain in the direction of the sciatic nerve that extends from the lower back through the thigh to the lower part of each leg. Weakness or other symptoms can be due to a variety of reasons, the prevalence of sciatica has increased dramatically in recent years.

In addition to sedentary lifestyles, the high prevalence of obesity and the older population are playing an important role in the increased incidence of sciatica. Advances in diagnostic technology have improved the accuracy of sciatica diagnosis and have been on the rise, resulting in higher reported rates being more frequent and affecting males more frequently, compared to females.

Market snapshot - 2024-2031

Global Market Size

USD 705.80 billion

Largest Segment

Non-steroidal anti-inflammatory drugs

Fastest Growth

Steroids

Growth Rate

4.1% CAGR

Global Sciatica Treatment Market ($ Bn)
Country Share for North america Region (%)
Global Sciatica Treatment Market By Drug Class ($ Bn)
Global Sciatica Treatment Market By Drug Class (%)

To get more reports on the above market click here to Buy The Report

Sciatica Treatment Market Segmental Analysis

By drug class, the sciatica treatment market is fragmented into non-steroidal anti-inflammatory drugs, steroids, antidepressants and others. Based on type, the sciatica treatment market is segmented into acute sciatica, chronic sciatica and others. On the basis of distribution channel, the sciatica treatment market is bifurcated into hospital pharmacies, retail & specialty pharmacies and online providers. Region wise, the sciatica treatment market is analyzed across North America, Europe, Asia Pacific and LAMEA.

Analysis by Drug Class

By 2022, the Non-Steroid Anti-Inflammatory Drug (NSAID) segment attained the highest revenue share, accounting for 39.47% share, and showed a dominant position in the global sciatica treatment market. This segment poised to continue its earlier position, in the 3rd forecast period, maintains its intensity through 2031.

The steroid segment is poised for tremendous growth, with an expected significant compound annual growth rate (CAGR) during the forecast period, holding the second highest position in the global sciatica treatment market. Steroids, especially corticosteroids, are mostly prescribed for the treatment of sciatica due to their potent anti-inflammatory properties. This trend is expected to be key to the segment’s growth.

Analysis by Distribution Channel

The online user segment plays a key role in the global sciatica treatment market by providing a digital platform for the dissemination of information, advice and access to relevant resources. In today’s healthcare landscape, online forums are an invaluable resource for individuals seeking information about sciatica symptoms, treatment options, and preventive measures. This resource provides advice on authenticity and is convenient, allowing patients to communicate remotely with health care providers.

The hospital pharmaceuticals segment played a significant role in contributing the largest revenue share to the global sciatica treatment market by 2022. The near-term figures suggest a steady growth trajectory for this category .

Global Sciatica Treatment Market By Drug Class, 2022 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Sciatica Treatment Market Regional Insights

North America is expected to witness the largest growth, with a projected compound annual growth rate (CAGR) of 15.6% during the forecast period by 2022. This robust growth is due to the high prevalence of sciatica in North America, supported by better services and payment management. All these factors contribute to the expanding global sciatica treatment market in North America. Notably, nonsteroidal anti-inflammatory drugs (NSAIDs) represent the most commonly prescribed category for sciatica treatment, known for their laboratory availability.

Asia-Pacific is poised for significant growth, projected to register a compound annual growth rate (CAGR) of 5.8% by 2022. This forecast presents exciting opportunities for forecasting sciatica treatment market participants throughout the period. Key factors contributing to this expected growth are an aging population, improving awareness and diagnosis of sciatica, and continued expansion of health care in developing countries in the region.

Global Sciatica Treatment Market By Region, 2024-2031
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Sciatica Treatment Market Dynamics

Drivers

Rise in Incidence of Chronic Sciatica

  • Sciatica is a common condition that affects up to 43% of the population throughout their lifetime, affecting approximately 10-40% of the population, with higher rates seen in older age. Both chronic and acute sciatica, an increase in individuals acts as a key driver of growth of the global sciatica treatment market. According to the study, sciatica affects a large percentage of the general population, ranging from 10-40%, and increases in age groups have been accomplished Notably, adults aged 20-59 exhibit a prevalence of 13.1%, while those aged 60 and older 19.2% incidence rate, highlighting the increasing impact of population age.

Restraints

Increased Costs of Certain Treatments

  • Surgeries such as microdiscectomy or spinal fusion, which are often recommended for sciatica, come with a high cost. In addition, emerging therapies such as stem cell therapy, while promising, are extremely costly, and insurance coverage likely may not extend to these procedures. The high costs associated with these treatments are a major barrier, especially for patients in low- and middle-income countries where health resources are already strained, limiting access to certain treatments.

Request Free Customization of this report to help us to meet your business objectives.

Sciatica Treatment Market Competitive Landscape

The competitive environment of the global Sciatica Treatment market is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor.

Top Player’s Company Profiles

  • Abbott Laboratories(United States)
  • Johnson and Johnson (United States)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Aurobindo Pharma Ltd. (India)
  • Zydus Cadila(India)
  • Glenmark Pharmaceuticals Ltd. (India)
  • Amneal Pharmaceuticals LLC (United States)
  • Jubilant Life Sciences Ltd. (India)
  • Hikma Pharmaceuticals PLC. (United Kingdom)
  • Mylan N.V.(Netherlands)
  • Horizon Therapeutics Plc. (Ireland)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Alkem Labs (India)
  • SCILEX Pharmaceuticals, Inc (United States)
  • Seikagaku Corporation (Japan)
  • Kolon Life Science, Inc. (South Korea)

Recent Developments

  • In March 2022, Sorrento Therapeutics, Inc. will have 100,000 shares. (NASDAQ:SRN) becomes the largest company in the world. The trial demonstrated the efficacy and safety of SP-102, with sustained pain relief demonstrated over 12 weeks.
  • In December 2021, the United States Food and Drug Administration (FDA) granted Fast Track designation for SP-102, primarily injectable dexamethasone sodium phosphate viscous gel formulation. This designation confirms FDA's demonstrated efficacy of SP-102, regulatory review system, emphasizing the importance of this new treatment modality in the treatment of sciatica.

Sciatica Treatment Key Market Trends

  • Advances in diagnostic and imaging technology, particularly MRI and CT scans, have had a transformative effect on the treatment of sciatica. These technological innovations have revolutionized the diagnosis of the causes of sciatica, enabling faster and more accurate diagnosis and early intervention. Early diagnosis is essential to prevent progression of chronic weakness. Improved accuracy in diagnosis, due to advanced imaging technology, positively impacts the clinical landscape by empowering healthcare professionals to intervene faster and more effectively, not that this provides not only improves patient outcomes, but also prevents the longevity of the condition and associated disability. Consequently, the increasing prevalence of sciatica acts as a key driver for the growth of the global sciatica treatment market.

Sciatica Treatment Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research. The increasing prevalence of sciatica is a major factor driving the demand for advanced treatments, thus driving the growth of the global sciatica treatment market. Furthermore, the continued availability of treatment options through technological advancements, with rising healthcare costs in the world all inclusive, helps the sciatica treatment work on the right track. If we see a shift towards strategic improvement, reflecting an obvious commitment to improving patient outcomes, reducing therapeutic use there will be a reduction in focused research and development activities as the discovery of more effective and less invasive treatments to meet the various needs of patients is anticipated to further boost the global sciatica treatment market size during the forecast period.

Report Metric Details
Market size value in 2022 USD 705.80 billion
Market size value in 2031 USD 1013.30 billion
Growth Rate 4.1%
Base year 2023
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Drug class
    • Non-steroidal anti-inflammatory drugs, Steroids, Antidepressants and Others
  • Type
    • Acute sciatica, Chronic sciatica, and Others
  • Distribution channel
    • Hospital pharmacies, Retail & specialty pharmacies, and Online providers
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Abbott Laboratories(United States)
  • Johnson and Johnson (United States)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Aurobindo Pharma Ltd. (India)
  • Zydus Cadila(India)
  • Glenmark Pharmaceuticals Ltd. (India)
  • Amneal Pharmaceuticals LLC (United States)
  • Jubilant Life Sciences Ltd. (India)
  • Hikma Pharmaceuticals PLC. (United Kingdom)
  • Mylan N.V.(Netherlands)
  • Horizon Therapeutics Plc. (Ireland)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Alkem Labs (India)
  • SCILEX Pharmaceuticals, Inc (United States)
  • Seikagaku Corporation (Japan)
  • Kolon Life Science, Inc. (South Korea)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Sciatica Treatment Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Sciatica Treatment Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Sciatica Treatment Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Sciatica Treatment Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Sciatica Treatment Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Sciatica Treatment Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Sciatica Treatment Market size was valued at USD 705.80 billion in 2022 and is poised to grow from USD 734.74 billion in 2023 to USD 1013.30 billion by 2031, growing at a CAGR of 4.1% in the forecast period (2024-2031).

The competitive environment of the Sciatica Treatment market is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor. 'Abbott Laboratories(United States)', 'Johnson and Johnson (United States)', 'Teva Pharmaceutical Industries Ltd. (Israel)', 'Aurobindo Pharma Ltd. (India)', 'Zydus Cadila(India)', 'Glenmark Pharmaceuticals Ltd. (India)', 'Amneal Pharmaceuticals LLC (United States)', 'Jubilant Life Sciences Ltd. (India)', 'Hikma Pharmaceuticals PLC. (United Kingdom)', 'Mylan N.V.(Netherlands)', 'Horizon Therapeutics Plc. (Ireland)', 'Sun Pharmaceutical Industries Ltd. (India)', 'Alkem Labs (India)', 'SCILEX Pharmaceuticals, Inc (United States)', 'Seikagaku Corporation (Japan)', 'Kolon Life Science, Inc. (South Korea)'

Sciatica is a common condition that affects up to 43% of the population throughout their lifetime, affecting approximately 10-40% of the population, with higher rates seen in older age. Both chronic and acute sciatica, an increase in individuals acts as a key driver of growth of the sciatica treatment market. According to the study, sciatica affects a large percentage of the general population, ranging from 10-40%, and increases in age groups have been accomplished Notably, adults aged 20-59 exhibit a prevalence of 13.1%, while those aged 60 and older 19.2% incidence rate, highlighting the increasing impact of population age.

Advances in diagnostic and imaging technology, particularly MRI and CT scans, have had a transformative effect on the treatment of sciatica. These technological innovations have revolutionized the diagnosis of the causes of sciatica, enabling faster and more accurate diagnosis and early intervention. Early diagnosis is essential to prevent progression of chronic weakness. Improved accuracy in diagnosis, due to advanced imaging technology, positively impacts the clinical landscape by empowering healthcare professionals to intervene faster and more effectively, not that this provides not only improves patient outcomes, but also prevents the longevity of the condition and associated disability. Consequently, the increasing prevalence of sciatica acts as a key driver for the growth of the sciatica treatment market.

North America is expected to witness the largest growth, with a projected compound annual growth rate (CAGR) of 15.6% during the forecast period by 2022. This robust growth is due to the high prevalence of sciatica in North America, supported by better services and payment management. All these factors contribute to the expanding sciatica treatment market in North America. Notably, nonsteroidal anti-inflammatory drugs (NSAIDs) represent the most commonly prescribed category for sciatica treatment, known for their laboratory availability.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Sciatica Treatment Market

Product ID: SQMIG35A2822

$5,300
BUY NOW GET FREE SAMPLE